For investors seeking momentum, AGFiQ US Market Neutral Anti-Beta Fund (BTAL - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 21.2% from its 52-week low price of $12.73/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
BTAL in Focus
The underlying Dow Jones U.S. Thematic Market Neutral Anti-Beta Index is a long/short market neutral index that is dollar-neutral. The fund charges 76 bps in fees (see all Long-Short ETFs here).
Why the Move?
Since markets remained volatile lately and there was a bloodbath in the global market at the start of August owing mainly to renewed U.S.-China trade tensions and China’s yuan devaluation, this defensive ETF gained strength.
More Gains Ahead?
The fund has a positive weighted alpha of 19.50. So, there is definitely still some promise for those who want to ride on this surging ETF a little longer, especially if uncertainty remains in the market.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>